189 related articles for article (PubMed ID: 9489728)
1. Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain.
Bunin MA; Prioleau C; Mailman RB; Wightman RM
J Neurochem; 1998 Mar; 70(3):1077-87. PubMed ID: 9489728
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission.
Bunin MA; Wightman RM
J Neurosci; 1998 Jul; 18(13):4854-60. PubMed ID: 9634551
[TBL] [Abstract][Full Text] [Related]
3. In vivo electrochemical evidence for simultaneous 5-HT and histamine release in the rat substantia nigra pars reticulata following medial forebrain bundle stimulation.
Hashemi P; Dankoski EC; Wood KM; Ambrose RE; Wightman RM
J Neurochem; 2011 Sep; 118(5):749-59. PubMed ID: 21682723
[TBL] [Abstract][Full Text] [Related]
4. Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat.
Bagdy E; Solyom S; Harsing LG
Brain Res Bull; 1998; 45(2):203-8. PubMed ID: 9443841
[TBL] [Abstract][Full Text] [Related]
5. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography.
Pejchal T; Foley MA; Kosofsky BE; Waeber C
Br J Pharmacol; 2002 Mar; 135(5):1115-22. PubMed ID: 11877317
[TBL] [Abstract][Full Text] [Related]
6. Brain dopamine and serotonin differ in regulation and its consequences.
Hashemi P; Dankoski EC; Lama R; Wood KM; Takmakov P; Wightman RM
Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11510-5. PubMed ID: 22778401
[TBL] [Abstract][Full Text] [Related]
7. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
[TBL] [Abstract][Full Text] [Related]
8. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors.
Hopwood SE; Stamford JA
Neuropharmacology; 2001 Sep; 41(4):433-42. PubMed ID: 11543763
[TBL] [Abstract][Full Text] [Related]
10. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
[TBL] [Abstract][Full Text] [Related]
12. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Kelly E; Jenner P; Marsden CD
J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
[TBL] [Abstract][Full Text] [Related]
13. Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine.
McQuade R; Sharp T
Neuroscience; 1995 Oct; 68(4):1079-88. PubMed ID: 8544983
[TBL] [Abstract][Full Text] [Related]
14. MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry.
Iravani MM; Muscat R; Kruk ZL
Synapse; 1999 Jun; 32(3):212-24. PubMed ID: 10340631
[TBL] [Abstract][Full Text] [Related]
15. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated.
Lucas G; De Deurwaerdère P; Porras G; Spampinato U
Neuropharmacology; 2000 Aug; 39(11):1984-95. PubMed ID: 10963742
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.
Ferris RM; Brieaddy L; Mehta N; Hollingsworth E; Rigdon G; Wang C; Soroko F; Wastila W; Cooper B
J Pharm Pharmacol; 1995 Sep; 47(9):775-81. PubMed ID: 8583392
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
18. Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata.
Threlfell S; Cragg SJ; Kalló I; Turi GF; Coen CW; Greenfield SA
J Neurosci; 2004 Oct; 24(40):8704-10. PubMed ID: 15470136
[TBL] [Abstract][Full Text] [Related]
19. Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice.
Owesson CA; Hopwood SE; Callado LF; Seif I; McLaughlin DP; Stamford JA
Eur J Neurosci; 2002 May; 15(9):1516-22. PubMed ID: 12028362
[TBL] [Abstract][Full Text] [Related]
20. Fast cyclic voltammetry can be used to measure stimulated endogenous 5-hydroxytryptamine release in untreated rat brain slices.
O'Connor JJ; Kruk ZL
J Neurosci Methods; 1991 Jun; 38(1):25-33. PubMed ID: 1921465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
